Works matching DE "DARUNAVIR"


Results: 426
    1
    2
    3
    4
    5
    6
    7

    HIV medication-based urolithiasis.

    Published in:
    Clinical Kidney Journal, 2014, v. 7, n. 2, p. 121, doi. 10.1093/ckj/sfu008
    By:
    • Izzedine, Hassane;
    • Lescure, François Xavier;
    • Bonnet, Fabrice
    Publication type:
    Article
    8
    9
    10
    11
    12

    Africa.

    Published in:
    Journal of Global Health, 2012, v. 2, n. 2, p. 1, doi. 10.7189/jogh.02.020201
    Publication type:
    Article
    13
    15
    16
    17

    Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial.

    Published in:
    Journal of the International AIDS Society, 2022, v. 25, n. 6, p. 1, doi. 10.1002/jia2.25905
    By:
    • Avihingsanon, Anchalee;
    • Hughes, Michael D.;
    • Salata, Robert;
    • Godfrey, Catherine;
    • McCarthy, Caitlyn;
    • Mugyenyi, Peter;
    • Hogg, Evelyn;
    • Gross, Robert;
    • Cardoso, Sandra W.;
    • Bukuru, Aggrey;
    • Makanga, Mumbi;
    • Badal‐aesen, Sharlaa;
    • Mave, Vidya;
    • Ndege, Beatrice Wangari;
    • Fontain, Sandy Nerette;
    • Samaneka, Wadzanai;
    • Secours, Rode;
    • Van Schalkwyk, Marije;
    • Mngqibisa, Rosie;
    • Mohapi, Lerato
    Publication type:
    Article
    18
    19

    Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.

    Published in:
    PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0209911
    By:
    • Bernardino, Jose I.;
    • Mocroft, Amanda;
    • Wallet, Cedrick;
    • de Wit, Stéphane;
    • Katlama, Christine;
    • Reiss, Peter;
    • Mallon, Patrick W.;
    • Richert, Laura;
    • Molina, Jean-Michel;
    • Knobel, Hernando;
    • Morlat, Philippe;
    • Babiker, Abdel;
    • Pozniac, Anton;
    • Raffi, Francois;
    • Arribas, Jose R.;
    • null, null
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 1, p. 105, doi. 10.1007/s10156-010-0082-4
    By:
    • Nakamura, Hitomi;
    • Miyazaki, Naoko;
    • Hosoya, Noriaki;
    • Koga, Michiko;
    • Odawara, Takashi;
    • Kikuchi, Tadashi;
    • Koibuchi, Tomohiko;
    • Kawana-Tachikawa, Ai;
    • Fujii, Takeshi;
    • Miura, Toshiyuki;
    • Iwamoto, Aikichi
    Publication type:
    Article
    34
    35
    36
    37

    Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.

    Published in:
    2018
    By:
    • Lê, Minh P;
    • Chaix, Marie-Laure;
    • Chevret, Sylvie;
    • Bertrand, Julie;
    • Raffi, François;
    • Gallien, Sébastien;
    • Abbassi, El Mountacer Billah El;
    • Katlama, Christine;
    • Delobel, Pierre;
    • Yazdanpanah, Yazdan;
    • Lê, Minh P;
    • Raffi, François;
    • Gallien, Sébastien;
    • El Abbassi, El Mountacer Billah;
    • Saillard, Juliette;
    • Molina, Jean-Michel;
    • Peytavin, Gilles;
    • ANRS 165 DARULIGHT Study Group
    Publication type:
    journal article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK.

    Published in:
    2016
    By:
    • El Bouzidi, Kate;
    • White, Ellen;
    • Mbisa, Jean L.;
    • Sabin, Caroline A.;
    • Phillips, Andrew N.;
    • Mackie, Nicola;
    • Pozniak, Anton L.;
    • Tostevin, Anna;
    • Pillay, Deenan;
    • Dunn, David T.;
    • UK HIV Drug Resistance Database;
    • (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees;
    • UK HIV Drug Resistance Database (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees
    Publication type:
    journal article